These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5548252)

  • 21. [SIGNIFICANCE OF ALDOSTERONE IN THE PATHOGENESIS OF THE EDEMATOUS AND HYPERTENSIVE SYNDROME IN KIDNEY DISEASES].
    GERASIMOVA EN; PALEEVA FM; RATNER NA
    Ter Arkh; 1964 Mar; 36():40-6. PubMed ID: 14183834
    [No Abstract]   [Full Text] [Related]  

  • 22. THE HYPERTENSIVE PATIENT. METHOD OF STUDY.
    KINSEY D; WHITELAW GP
    Am J Surg; 1964 Jan; 107():5-13. PubMed ID: 14099504
    [No Abstract]   [Full Text] [Related]  

  • 23. [Determination of homeostatic kidney function in the diagnosis of chronic glomerulonephritis].
    Ratner MJ
    Z Urol Nephrol; 1977 Dec; 70(12):871-6. PubMed ID: 607691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose titration studies in patients with chronic progressive renal disease.
    Rieselbach RE; Shankel SW; Slatopolsky E; Lubowitz H; Bricker NS
    J Clin Invest; 1967 Feb; 46(2):157-63. PubMed ID: 6018755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical value of the determination of beta 2 microglobulin in kidney diseases].
    Potsybina VV; Baran EIa
    Urol Nefrol (Mosk); 1984; (3):53-6. PubMed ID: 6377647
    [No Abstract]   [Full Text] [Related]  

  • 26. [Personal studies of calcium-phosphate metabolism in kidney diseases].
    Krauz A
    Pol Tyg Lek; 1970 Jan; 25(2):47-50. PubMed ID: 5415361
    [No Abstract]   [Full Text] [Related]  

  • 27. [The rapidity of potassium metabolism in kidney diseases].
    Veisman VA; Ramzaev PV; Ushakova AP; Shapiro EL; Smirnov BI
    Med Radiol (Mosk); 1972 Aug; 17(8):65-9. PubMed ID: 4664244
    [No Abstract]   [Full Text] [Related]  

  • 28. [The renal excretion of copper in humans. Studies on the metabolism of trace elements VI (author's transl)].
    Mertz DP; Wilk G; Koschnick R
    Z Klin Chem Klin Biochem; 1973 Jan; 11(1):15-9. PubMed ID: 4804136
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal failure and hypertension in tropical Africa--a pre-dialysis experience from Nigeria.
    Ojogwu LI; Anah CO
    East Afr Med J; 1983 Jul; 60(7):478-84. PubMed ID: 6641560
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of oral diazoxide on hypertension and sodium excretion in chronic renal failure.
    Thurston H; Pohl JE; Swales JD
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():175s-9. PubMed ID: 4522165
    [No Abstract]   [Full Text] [Related]  

  • 31. Total exchangeable sodium in chronic nephropathy with and without hypertension.
    Friis T; Nielsen B; Willumsen J
    Acta Med Scand; 1970; 1-2(1):65-74. PubMed ID: 4918806
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aspects of water-electrolyte metabolism studied with muscle needle-biopsy. Findings in cardiac insufficiency, hepatic cirrhosis, diabetes mellitus and chronic renal insufficiency].
    Ossi E; Mioni G; D'Angelo A; Lupo A; Valvo E; Maschio G
    G Clin Med; 1974 Feb; 55(2):131-44. PubMed ID: 4419276
    [No Abstract]   [Full Text] [Related]  

  • 33. [Calcium balance in chronic renal insufficiency].
    Graziani G; Della Grazia M; Imbasciati E; Ponticelli C; Redaelli B
    Minerva Nefrol; 1967; 14(3):125-9. PubMed ID: 5596513
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pre-existing hypertension and pregnancy].
    Machado DF
    Matern Infanc (Sao Paulo); 1970; 29(1):17-63. PubMed ID: 5516899
    [No Abstract]   [Full Text] [Related]  

  • 35. [Renal water homeostasis. Possibility of clinical interpretation].
    Radice C; D'Amico E; Torti G
    Minerva Pediatr; 1971 Mar; 23(13):576-85. PubMed ID: 5576858
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acid-alkaline balance characteristics in children with kidney diseases].
    Vel'tishchev IuE; Reshetnikova AD; Mukhina IuG
    Vopr Okhr Materin Det; 1967 Sep; 12(9):14-8. PubMed ID: 5610338
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes of fractional renal clearance of magnesium after spironolactone administration in normal subjects.
    Mountokalakis T; Merikas G; Skipelitis P; Vardakis M; Sevastos N; Alivisatos J
    Klin Wochenschr; 1975 Jul; 53(13):633-5. PubMed ID: 1177408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Content of total metabolic sodium in arterial hypertension of varying origin].
    Shkhvatsabaia IK; Kramer AA; Pavleeva FM; Suvorov IuI
    Kardiologiia; 1976 Jul; 16(7):48-56. PubMed ID: 978879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis.
    Tikhonov I; Rebenok A; Chyzh A
    Nephrol Dial Transplant; 1997 Dec; 12(12):2557-61. PubMed ID: 9430851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential diagnostic value of clearance].
    Mertz DP
    Dtsch Med Wochenschr; 1965 Oct; 90(43):1919-21. PubMed ID: 5831645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.